France
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
14.08%
|
Dec. 31, 2023 | USD 75.53 | 2.94% |
|
France |
|
2 |
8.80%
|
Dec. 31, 2023 | USD 3.53 | -0.92% |
|
France |
|
3 |
8.04%
|
Dec. 31, 2023 | USD 107.78 | 1.15% |
|
France |
|
4 |
3.91%
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
5 |
-8.76%
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
6 |
-25.00%
|
Dec. 31, 2023 | USD 3.21 | 17.34% |
|
France |
|
7 |
-26.75%
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
8 |
-29.13%
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
9 |
-30.25%
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
10 |
-33.24%
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
11 |
-52.10%
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
12 |
-56.91%
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
13 |
-71.77%
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
14 |
-99.27%
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
15 |
-150.69%
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
16 |
-385.63%
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
17 |
-538.93%
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
The Vaccines company in France with the highest Return on Capital Employed (ROCE) is Vetoquinol SA (Paris Stock Exchange: VETO.PA) at 14.08%.
The Vaccines company in France with the lowest Return on Capital Employed (ROCE) is Inventiva S.A. (Paris Stock Exchange: IVA.PA) at -538.93%.
The top 10 Vaccines companies in France by Return on Capital Employed (ROCE) are Vetoquinol SA, genOway SA, Sanofi, Eurobio Scientific SA, Innate Pharma S.A., Valneva SE, Novacyt S.A., Valbiotis SA, Aelis Farma SA and OSE Immunotherapeutics SA.
The bottom 10 Vaccines companies in France by Return on Capital Employed (ROCE) are Inventiva S.A., Adocia SA, AB Science S.A., MedinCell S.A., Nanobiotix S.A., DBV Technologies S.A., ABIVAX SA, OSE Immunotherapeutics SA, Aelis Farma SA and Valbiotis SA.